Biomarin Pharmaceutical Inc (NASDAQ:BMRN)
| 118.98 BATS BZX Real-Time Price As of 1:40pm ET |  -0.99 / -0.83%Today’s Change | 62.88 Today|||52-Week Range 131.95 | +40.72% Year-to-Date |
Latest BMRN News | Press Releases
| Biotech Bonanza - Second Half Outlook Jul 28 / Seeking Alpha - Paid Partner Content | 3 Biotech Stocks With Big Incoming Catalysts Jul 25 / MotleyFool.com - Paid Partner Content |
| 3 Unstoppable Stocks to Buy Before the Next Market Crash Jul 25 / MotleyFool.com - Paid Partner Content | Rising Risk? Here's What You Can Buy Jul 24 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 119.97 |
| Today’s open | 119.77 |
| Day’s range | 118.33 - 120.36 |
| Volume | 11,404 |
| Average volume (3 months) | 1,519,074 |
| Market cap | $21.6B |
Data as of 1:40pm ET, 08/06/2020
Growth & Valuation
| Earnings growth (last year) | +69.46% |
| Earnings growth (this year) | +318.85% |
| Earnings growth (next 5 years) | +51.10% |
| Revenue growth (last year) | +12.63% |
| P/E ratio | 188.9 |
| Price/Sales | 8.98 |
| Price/Book | 6.89 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRNAModerna Inc | -2.34 | -3.09% |
| EXASExact Sciences Corp | -3.09 | -3.36% |
| NBIXNeurocrine Bioscienc... | -2.84 | -2.39% |
| IMMUImmunomedics Inc | -1.30 | -2.93% |
Data as of 1:45pm ET, 08/06/2020
Financials
| Next reporting date | October 22, 2020 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $1.7B |
| Annual profit (last year) | -$23.8M |
| Net profit margin | -1.41% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Rafael, California |
Forecasts
